If you are wondering whether Moderna's share price really reflects what the business is worth today, you are not alone. That is exactly what this article will unpack. The stock recently closed at ...

If you are wondering whether Moderna's current share price reflects its true potential, or if the market is still anchored to ...

Why Moderna Stock Is Back on Investors’ Radar Moderna (MRNA) has reappeared on many watchlists after a mixed set of signals, ...

Including the settlement payment, Moderna now expects to end 2026 with between $4.5 billion and $5 billion in cash and cash ...

Two stocks are standing out in premarket trading this Wednesday morning. Moderna (Nasdaq: MRNA) is up 8.9% and Ross Stores (Nasdaq: ROSS) is up 6.6% as of 8:00 AM ET, each moving on a distinct ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 9:30 AM EDTCompany ParticipantsLavina Talukdar - Senior VP & ...

Immatics N.V. remains a speculative Buy, driven by progress with anzu-cel in 2L melanoma and a robust cell therapy pipeline.

Here are some of the stocks making the biggest moves in midday trading. CoreWeave — The cloud company's stock popped 8% after ...

Check out the companies making headlines before the bell. Moderna — The biotechnology firm rose nearly 11% after it said it agreed to pay up to $2.25 billion to settle a lawsuit with Biopharma Corp.

Moderna (NASDAQ: MRNA), Strategy (NASDAQ: MSTR), and Trade Desk (NASDAQ: TTD)—tells three very different stories. All three ...

Moderna (MRNA) closed at $41.95 in the latest trading session, marking a +2.29% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.47%. Meanwhile, the Dow ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.